DPH updates COVID-19 numbers for Tuesday, May 19 The Delaware Division of Public Health (DPH) announced 168 new positive cases have been confirmed and that 7 more Delawareans — 304 in all — have passed away due to complications from COVID-19. The deceased range in age from 21 to 103 years old. As of May 19, the state's COVID-19 case statistics cumulatively since March 11 include 8,037 total laboratory-confirmed cases — 2,845 of them in New Castle County, 1,238 in Kent County and 3,904 in Sussex County. The state said preliminary data based on reporting by state and commercial laboratories, indicate there have been 36,095 negative cases. There are 236 Delawareans who are currently hospitalized. To date, 3,760 Delawareans who have tested positive have recovered.

---

Multi-system Inflammatory Syndrome in Children (MIS-C) potentially linked to COVID-19 The Delaware Division of Public Health is issuing a health advisory to ensure providers are aware of MIS-C potentially association with COVID-19, and to provide guidance on reporting of cases to DPH and testing of patients who present with this disease. As of May 12, 2020, Delaware has reportedly identified three cases. If there is a strong clinical suspicion of MIS-C call 1- 888-295-5156 to consult with the DPH Office of Infectious Disease, or report through reportdisease@delaware.gov. This syndrome has features which overlap with Kawasaki Disease and Toxic Shock Syndrome. Inflammatory markers may be elevated, and fever and abdominal symptoms may be prominent. Rash also may be present. Myocarditis and other cardiovascular changes may be seen.

Symptoms

• An individual aged < 21 years presenting with fever1, laboratory evidence of inflammation2, and evidence of clinically severe illness requiring hospitalization, with multisystem (>2) organ involvement (cardiac, renal, respiratory, hematologic, gastrointestinal, dermatologic or neurological);
• No alternative plausible diagnoses;
• Positive for current or recent SARS-CoV-2 infection by RT-PCR, serology, or antigen test; or COVID-19 exposure within the four (4) weeks prior to the onset of symptoms1 Fever >38.0°C for ≥24 hours, or report of subjective fever lasting ≥24 hours2 Including, but not limited to, one or more of the following: an elevated C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), fibrinogen, procalcitonin, d-dimer, ferritin, lactic acid dehydrogenase (LDH), or interleukin 6 (IL-6), elevated neutrophils, reduced lymphocytes and low albumin